Prognostic Influence of Mutational Status in Resected Non-Small Cell Lung Cancer: the KRAS G12V Worse Value

Authors :: Anne-Claire Voegeli
Jérémie Reeb
Pierre Emmanuel Falcoz
N Santelmo
Michèle Beau-Faller
Mickaël Schaeffer
Gilbert Massard
Anne Olland
Benoit Romain
S. Renaud
Source :: Annals of Oncology. 26:i18
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Hematology
medicine.disease
medicine.disease_cause
Internal medicine
medicine
Mutational status
KRAS
Non small cell
Lung cancer
business
Value (mathematics)

Full Text Access

Tools